Aditya Vikram Pachisia

Dec 14, 2023 | onlinelibrary.wiley.com | Aditya Vikram Pachisia |Alka Kumari |Shubham Mehta |Anam Ahmed

Background and Aim While European Society of Pediatric Gastroenterology Hepatology and Nutrition advocates a no-biopsy pathway for the diagnosis of celiac disease (CeD) in children if IgA anti-tissue transglutaminase antibody (anti-tTG ab) titer is ≥10-fold upper limit of normal (ULN) and have a positive IgA anti-endomysial antibody (EMA); the data for anti-tTG Ab titer-based diagnosis of CeD in adults is still emerging.

Nov 14, 2023 | onlinelibrary.wiley.com | Shubham Mehta |Ankit Agarwal |Alka Singh |Aditya Vikram Pachisia

Background and Aim Celiac disease (CeD) has now become a global disease with a worldwide prevalence of 0.67%. Despite being a common disease, CeD is often not diagnosed and there is a significant delay in its diagnosis. We reviewed the impact of the delay in the diagnosis on the severity of manifestations of CeD. Methods We reviewed clinical records of 726 consecutive patients with CeD from the Celiac Clinic database and the National Celiac Disease Consortium database.